Showing results (61-70 of 218) with videos related to
Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammationSimi Ali, Helen Robertson, Julie H Wain, et al.Rheumatology (Oxford, England)|July 24, 2021
Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?Amanda D Busby, James Wason, Arthur G Pratt, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 14, 2019
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 28, 2020
Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.Rheumatology (Oxford, England)|February 13, 2019
Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patientsKundan Iqbal, Dennis W Lendrem, Ben Hargreaves, et al.Rheumatology (Oxford, England)|March 8, 2022
The role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort dataAmanda D Busby, James Wason, Arthur G Pratt, et al.RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
A negative feedback loop mediated by STAT3 limits human Th17 responsesHarriet A Purvis, Amy E Anderson, David A Young, et al.Arthritis Research & Therapy|December 6, 2012
Disease activity and cognition in rheumatoid arthritis: an open label pilot studyGraham Raftery, Jiabao He, Ruth Pearce, et al.Arthritis Research & Therapy|September 3, 2011
Integrated safety in tocilizumab clinical trialsMichael H Schiff, Joel M Kremer, Angelika Jahreis, et al.Pageof 22